Product Information
SPIRIVA RESPIMAT 2.5 MCG INH is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $126.1198 per GM under NDC 00597010061. Its NADAC has been published 601 times since Feb 18, 2015.
FDA first approved this application on Sep 24, 2014.
Strength
3.124 ug/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597010061
Classification
Brand
Dosage Form
SPRAY, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
TIOTROPIUM BROMIDE ANHYDROUSApproval Type
New Drug (NDA)
FDA Application
NDA021936FDA Approved
9/24/2014
On Market Since
9/30/2014
Pharmacological Classes
Price Statistics
The NADAC for SPIRIVA RESPIMAT 2.5 MCG INH has been published 601 times since Feb 18, 2015, and over the history we have for it it has risen 83.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $126.1198 per GM |
|---|---|
| All-time high | $126.4693 (Aug 14, 2024) |
| All-time low | $68.7713 (Feb 18, 2015) |
| 52-week high | $126.2176 |
| 52-week low | $126.1198 |
| Median price | $109.2058 |
| Average price | $106.9735 |
| Largest weekly change | +8.0% (Jan 10, 2018) |
| Weeks tracked | 601 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SPIRIVA RESPIMAT 2.5 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for SPIRIVA RESPIMAT 2.5 MCG INH, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $126.1198 per GM (NDC 00597010061), effective Aug 19, 2026.
How has the price of SPIRIVA RESPIMAT 2.5 MCG INH changed over time?
Over the history we have for it, the NADAC for SPIRIVA RESPIMAT 2.5 MCG INH has risen 83.4%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for SPIRIVA RESPIMAT 2.5 MCG INH?
Since Feb 18, 2015, the NADAC for SPIRIVA RESPIMAT 2.5 MCG INH has ranged from a low of $68.7713 (Feb 18, 2015) to a high of $126.4693 (Aug 14, 2024), with a median of $109.2058 per GM.
Are there cheaper alternatives to SPIRIVA RESPIMAT 2.5 MCG INH?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SPIRIVA RESPIMAT 2.5 MCG INH, is $109.2058 per GM — about 13% below SPIRIVA RESPIMAT 2.5 MCG INH.
Who manufactures SPIRIVA RESPIMAT 2.5 MCG INH?
SPIRIVA RESPIMAT 2.5 MCG INH (NDC 00597010061) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.